Back
Autolus Therapeutics PLC Quote, Financials, Valuation and Earnings
Sponsored
AUTL
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
AUTL
Autolus Therapeutics PLC
Last Price:
2.84
Seasonality Move:
0.84%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Autolus Therapeutics PLC Price Quote
$2.84
Autolus Therapeutics PLC Key Stats
Buy
51
Autolus Therapeutics PLC (AUTL)
is a Buy
Day range:
$2.69 - $2.90
52-week range:
$2.69 - $7.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.58%
Volume:
3.4M
Avg. volume:
2.1M
1-year change:
-29.88%
Market cap:
$755.8M
Revenue:
$1.7M
EPS:
$-1.22
How Much Does Autolus Therapeutics PLC Make?
Data Unavailable
Is Autolus Therapeutics PLC Growing As A Company?
Data Unavailable
Autolus Therapeutics PLC Stock Price Performance
-
Did Autolus Therapeutics PLC Stock Go Up Last Month?
Autolus Therapeutics PLC share price went down by -37.17% last month -
Did AUTL's Share Price Rise Over The Last Year?
AUTL share price fell by -29.88% over the past 1 year
What Is Autolus Therapeutics PLC 52-Week High & Low?
-
What Is Autolus Therapeutics PLC’s 52-Week High Share Price?
Autolus Therapeutics PLC has traded as high as $7.45 over the past 52 weeks -
What Is Autolus Therapeutics PLC’s 52-Week Low Share Price?
Autolus Therapeutics PLC has traded as low as $2.69 over the past 52 weeks
Autolus Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Autolus Therapeutics PLC?
-
How Much Debt Does Autolus Therapeutics PLC Have?
Total long term debt quarterly is $0 -
How Much Cash Does Autolus Therapeutics PLC Have?
Cash and short term investments quarterly total is $657.1M -
What Is Autolus Therapeutics PLC’s Book Value Per Share?
Book value per share is 1.79
Is Autolus Therapeutics PLC Cash Flow Positive?
-
What Is AUTL Cash Flow From Operations?
Cash flow from operations (TTM) is -$193.2M -
What Is Autolus Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $559.6M -
What Is Autolus Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$12.4M
Autolus Therapeutics PLC Return On Invested Capital
Data Unavailable
Autolus Therapeutics PLC Earnings Date & Stock Price
-
What Is Autolus Therapeutics PLC's Stock Price Today?
A single share of AUTL can be purchased today for 2.84 -
What Is Autolus Therapeutics PLC’s Stock Symbol?
Autolus Therapeutics PLC trades on the nasdaq under the ticker symbol: AUTL -
When Is Autolus Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Autolus Therapeutics PLC is scheduled on March 14, 2025 -
When Is AUTL's next ex-dividend date?
Autolus Therapeutics PLC's next ex-dividend date is November 22, 2024 -
How To Buy Autolus Therapeutics PLC Stock?
You can buy Autolus Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Autolus Therapeutics PLC Competitors
-
Who Are Autolus Therapeutics PLC's Competitors?
Below is a list of companies who compete with Autolus Therapeutics PLC or are related in some way:
Autolus Therapeutics PLC Dividend Yield
-
What Is AUTL Dividend Yield?
Autolus Therapeutics PLC’s dividend yield currently is 0% -
What Is Autolus Therapeutics PLC’s Payout Ratio?
Autolus Therapeutics PLC’s payout ratio is 0% -
When Did Autolus Therapeutics PLC Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Autolus Therapeutics PLC’s Dividend Per Share?
Autolus Therapeutics PLC pays a dividend of $0.00 per share
Autolus Therapeutics PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -41.99% |
Revenue: | 0% | -100% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 10.45 |
Upside from Last Price: | 267.96% |